The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors

• Iñigo Landa ,

  Contributed equally to this work with: Iñigo Landa, Sergio Ruiz-Llorente

  Affiliation Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Sergio Ruiz-Llorente ,

  Contributed equally to this work with: Iñigo Landa, Sergio Ruiz-Llorente

  Affiliation Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC), Autonomous University of Madrid (CSIC-UAM), Madrid, Spain

  ⨯
• Cristina Montero-Conde,

  Affiliations Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC), Autonomous University of Madrid (CSIC-UAM), Madrid, Spain

  ⨯
• Lucía Inglada-Pérez,

  Affiliations Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, ISCIII Centre for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain

  ⨯
• Francesca Schiavi,

  Affiliation Familial Cancer Clinic, Veneto Institute of Oncology IRCCS, Padova, Italy

  ⨯
• Susanna Leskelä,

  Affiliation Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Guillermo Pita,

  Affiliation Genotyping Unit-CEGEN, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Roger Milne,

  Affiliation Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Javier Maravall,

  Affiliation Hospital Universitario Arnau de Vilanova-IRB Lleida, Lleida, Spain

  ⨯
• Ignacio Ramos,

  Affiliation Hospital de Requena, Valencia, Spain

  ⨯
• Víctor Andía,

  Affiliation Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Paloma Rodríguez-Poyo,

  Affiliation Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Antonino Jara-Albarrán,

  Affiliation Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Amparo Meoro,

  Affiliation Hospital Universitario Reina Sofía, Murcia, Spain

  ⨯
• Cristina del Peso,

  Affiliation Hospital Universitario Reina Sofía, Murcia, Spain

  ⨯
• Luis Arribas,

  Affiliation Hospital Marina Alta, Denia, Spain

  ⨯
• Pedro Iglesias,

  Affiliation Hospital General de Segovia, Segovia, Spain

  ⨯
• Javier Caballero,

  Affiliation Hospital Reina Sofía, Córdoba, Spain

  ⨯
• Joaquín Serrano,

  Affiliation Hospital General Universitario de Alicante, Alicante, Spain

  ⨯
• Antonio Picó,

  Affiliation Hospital General Universitario de Alicante, Alicante, Spain

  ⨯
• Francisco Pomares,

  Affiliation Hospital Universitario San Juan de Alicante, Alicante, Spain

  ⨯
• Gabriel Giménez,

  Affiliation Hospital de Sabadell-Parc Taulí, Sabadell, Spain

  ⨯
• Pedro López-Mondéjar,

  Affiliation Hospital General Universitario de Elche, Elche, Spain

  ⨯
• Roberto Castello,

  Affiliation Civil Hospital, Verona, Italy

  ⨯
• Isabella Merante-Boschin,

  Affiliation Surgical Pathology, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Maria-Rosa Pelizzo,

  Affiliation Surgical Pathology, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Didac Mauricio,

  Affiliation Hospital Universitario Arnau de Vilanova-IRB Lleida, Lleida, Spain

  ⨯
• Giuseppe Opocher,

  Affiliations Familial Cancer Clinic, Veneto Institute of Oncology IRCCS, Padova, Italy, Department of Medical and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Cristina Rodríguez-Antona,

  Affiliations Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, ISCIII Centre for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain

  ⨯
• Anna González-Neira,

  Affiliation Genotyping Unit-CEGEN, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Xavier Matías-Guiu,

  Affiliation Hospital Universitario Arnau de Vilanova-IRB Lleida, Lleida, Spain

  ⨯
• Pilar Santisteban ,

  * E-mail: psantisteban@iib.uam.es (PS); mrobledo@cnio.es (MR)

  Affiliation Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC), Autonomous University of Madrid (CSIC-UAM), Madrid, Spain

  ⨯
•  [ ... ],
• Mercedes Robledo

  * E-mail: psantisteban@iib.uam.es (PS); mrobledo@cnio.es (MR)

  Affiliations Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, ISCIII Centre for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain

  ⨯
• [ view all ]
• [ view less ]